Electronic Resource
Development of a taxonomy for pharmaceutical interventions in HIV+ patients based on the CMO model
| العنوان: | Development of a taxonomy for pharmaceutical interventions in HIV+ patients based on the CMO model |
|---|---|
| المؤلفون: | Universidad de Sevilla. Departamento de Farmacología, Morillo Verdugo, Ramón Alejandro, Villarreal Arévalo, Andrea Lisbeth, Álvarez de Sotomayor Paz, María, Aguas Robustillo-Cortés, María de las |
| بيانات النشر: | Grupo Aula Medica S.L. 2016 |
| نوع الوثيقة: | Electronic Resource |
| مستخلص: | Objective: To agree on a proposal for pharmaceutical interventions and establish their classification taxonomy according to the CMO-Pharmaceutical Care Model (Capacity-Motivation- Opportunity). Method: A study conducted between March and May, 2016. Two phases of development were defined. A literature review was initially conducted. Then, the DELPHI-Rand-UCLA methodology was used in order to reach a consensus about those interventions selected, and to define the taxonomy. Fifteen (15) experts, specialists in Pharmaceutical Care for HIV+ patients, were selected. This selection was explicitly conducted, following a protocol in order to avoid any bias. An initial proposal was developed according to the interventions extracted from Phase 1. These were tentatively classified according to the CMO Model, in a category based on their design and utility. Three issues were raised from the initial question: Do you agree with the proposed classification? If not, there was an option to re-categorize. Additionally, they were asked about the importance, priority and impact to achieve pharmacotherapeutic objectives that they would assign to it. Interventions were classified according to the degree of agreement. Once a consensus was reached, the final taxonomy was established. Results: Eighteen (18) articles were finally considered. The initial proposal included 20 pharmaceutical interventions with the following classification: seven in Capacity, eight in Motivation, and five in Opportunity. Those interventions considered to have greater importance and priority were: Review and Validation, Safety, and Adherence. The interventions with the greatest impact were: Review and Validation, Coordination, Adherence, and Motivation. On the other hand, the lowest scores for importance were for: Planning and Social Coordination; and in terms of impact: Social Coordination. Conclusions: The taxonomy reached by consensus will allow to classify pharmaceutical interventions with the new model, and t |
| مصطلحات الفهرس: | HIV, M-Health, Motivation, Pharmaceutical care, Stratification, info:eu-repo/semantics/article |
| URL: | Farmacia Hospitalaria, 40 (6), 544-568. |
| الاتاحة: | Open access content. Open access content http://creativecommons.org/licenses/by-nc-nd/4.0 info:eu-repo/semantics/openAccess Attribution-NonCommercial-NoDerivatives 4.0 Internacional |
| ملاحظة: | Spanish English |
| Other Numbers: | SUE oai:idus.us.es:11441/95620 Morillo Verdugo, R.A., Villarreal Arévalo, A.L., Álvarez de Sotomayor Paz, M. y Aguas Robustillo-Cortés, M.d.l. (2016). Development of a taxonomy for pharmaceutical interventions in HIV+ patients based on the CMO model. Farmacia Hospitalaria, 40 (6), 544-568. 1130-6343 2171-8695 https://hdl.handle.net/11441/95620 10.7399/fh.2016.40.6.10567 1198025370 |
| المصدر المساهم: | UNIV DE SEVILLA From OAIster®, provided by the OCLC Cooperative. |
| رقم الانضمام: | edsoai.on1198025370 |
| قاعدة البيانات: | OAIster |
| الوصف غير متاح. |